A blood-based RNA modification and gene-expression signature detected hepatocellular carcinoma, including stage I disease.
The Manila Times on MSN
E-cigarettes can cause cancer in respiratory tissue
MOLECULAR biologists at the University of the Philippines Diliman (UPD) have uncovered direct cellular evidence demonstrating ...
The announcement from Merck & Co. and Moderna last month that their mRNA cancer vaccine had successfully lengthened patient ...
RNA therapeutics are moving beyond the liver into the brain, fat and muscle, with OLIX, Novartis and GSK expanding ...
After substantial weight loss on a very-low-carbohydrate diet, participants who switched to a diet rich in refined starch ...
CAMP4 Therapeutics Corporation ( CAMP ), a clinical-stage biopharmaceutical company developing RNA-targeting medicines, announced that the UK's Medicines and Healthcare Products Regulatory Agency ...
The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug ...
Announcing a new article publication for BIO Integration. Myocardial infarction (MI) is characterized by extensive immune ...
Dyne Therapeutics lead asset z-rostudirsen faces regulatory and confirmatory risks, with FDA approval likely. Find out why ...
Tech Times on MSN
AlphaGenome Atlas scores all 9 billion DNA mutations, doubles rare-disease hit rate
AlphaGenome Atlas, Google DeepMind's new 1-petabyte genomics database, pre-computes predicted molecular effects for all 9 ...
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing ...
Google DeepMind has released a huge new dataset that could make it easier for scientists to study how changes in our DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results